ARS Pharmaceuticals Inc —— 资产负债表 (NASDAQ:SPRY) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 333.47 M281.44 M233.19 M351.15 M327.65 M 负债总额 19.65 M8.55 M2.43 M94.36 M213.39 M 权益总额 313.81 M272.89 M230.76 M256.8 M114.26 M 负债及股东权益总额 333.47 M281.44 M233.19 M351.15 M327.65 M 总债务 5.85 M0——96.37 M 净债务 -248.2 M-273.9 M——-148.61 M

新闻

ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines (SPRY)

Leerink上调ARS Pharmaceuticals目标价,看好销售扩张

Leerink raises ARS Pharmaceuticals stock price target on sales expansion

ARS Pharmaceuticals第四季度业绩超预期,股价上涨

Earnings call transcript: ARS Pharmaceuticals beats Q4 2025 forecasts, stock rises

ARS Pharmaceuticals, Inc. (SPRY) Q4 2025 Earnings Call Transcript

ARS PharmaceuticalsQ1每股收益及营收超出预期

ARS Pharmaceuticals earnings beat by $0.01, revenue topped estimates

ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates

Canadian Natural to Report Q4 Earnings: What's in the Offing?

ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Raymond James重申ARS Pharmaceuticals股票强力买入评级